Home » Novartis Invests More in Singapore
Novartis Invests More in Singapore
Novartis is expanding its already ambitious investment program in Singapore. In tandem with the opening of a new pharmaceutical tableting facility there, the Swiss drug giant revealed plans to spend $700 million on a biopharmaceutical manufacturing plant.
Chemical and Engineering News
Upcoming Events
-
07May
-
14May
-
30May